Less than a month ago, a Canadian-based innovative mobile health and telemedicine company announced that it developed a mobile application to support patients who have been prescribed medical cannabis.
The company, Reliq Health Technologies (RHT.V) (RQHTF), offers a hardware and software solution that allows patients to receive high-quality care at home.
Today, Reliq announced that it entered into a memorandum of understanding (MOU) with Invictus MD Strategies Corp. (IMH.CN: CSE) (IVITF: OTC) to develop a mobile application for cannabis patients and consumers and their clinical care teams.
Invictus MD is focused on acquiring licensed producers for cannabis cultivation in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company is focused on three verticals: 1) Cannabis cultivation in Canada, 2) Cannabis fertilizer and nutrients, and 3) Data and Delivery.
Invictus has been very successful with its strategy of acquiring and divesting cannabis businesses. In December, the company paid a $1 million dividend to its shareholders ($0.07 a share).
From the CEO
Invictus MD Chairman/CEO Dan Kriznic said, “Our wholly owned subsidiary: Poda Technologies Ltd. (Poda) is set for a launch in Q2 2017 of its Poda Pod vaporizer product which will provide an effective, reliable and convenient way to vaporize cannabis that is designed to appeal to modern retail and medical consumers.”
The Poda Pod vaporizer was designed to connect to users’ smartphones to provide real time information about dosage, to provide product characteristics, to track remaining contents, to find vendors nearby, and to customize their experience.
The chairman also said it is excited to see how Reliq’s product can support Invictus patients. Reliq’s platform will give Invictus the ability to collect relevant consumer data such as usage trends, frequency of usage and other relevant insights to improve the overall experience for medical marijuana patients.
A Deal Without Compromise
We are favorable on this announcement as we believe the companies will discover significant synergy opportunities between the two businesses.
Invictus owns 33.3% of AB Laboratories Inc., a licensed medical cannabis producer under the ACMPR (based out of Hamilton, Ontario). AB received its cultivation license in October 2016 and expects to receive its sales license in the second quarter of 2017.
The company also will own 100% of PlanC BioPharm Inc., a licensed producer applicant, once it raises $8 million for the acquisition of land and construction of a 30,000 sq. ft. cultivation facility. Invictus expects to receive a cultivation license in the fourth quarter of 2017.
We are favorable on the assets owned by Invictus as well as the opportunity for Reliq within these assets. This is a relationship to watch as we expect to see some exciting developments announced by these two companies.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
